Prototype for rapid blood donor screening
Active Other Transaction Agreement Awarded Last action
- Contract number
- HT94252490030
- Awardee
-
Biolytical Laboratories Inc. UEI TMHZFENUQ2A9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $29,146,957
Award facts
- Contract value 66% obligated
- $44,179,636.38 Current and potential, with all options
- Completion date 62% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $15,087,274 | |
| Supplemental Agreement for work within scope | $8,605,144 | |
| Supplemental Agreement for work within scope | $1,912,540 | |
| Original award | $3,542,000 |
About this award
The Defense Health Agency awarded an Other Transaction Agreement to Biolytical Laboratories Inc. for a prototype for rapid blood donor screening, with a ceiling value of $44.2 million, as of September 20, 2024. The OTA operates outside the FAR and sits within the Department of Defense's authority to pursue innovation prototypes. Work is performed in Ottawa, Ontario, Canada. The agreement runs through January 31, 2028.
Quick answers
Who was awarded contract HT94252490030?
HT94252490030 was awarded to Biolytical Laboratories Inc. by Defense Health Agency (Department of Defense) on September 20, 2024.
How much is contract HT94252490030 worth?
The government has obligated $29,146,957 on HT94252490030. Its current value, with exercised options, is $44,179,636.
Was contract HT94252490030 competed?
The extent of competition for HT94252490030 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award